Biostime International Holdings Ltd:企業の戦略・SWOT・財務分析

【英語タイトル】Biostime International Holdings Ltd - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(MLINE7091022)・商品コード:MLINE7091022
・発行会社(調査会社):MarketLine
・発行日:2017年1月31日
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:消費財
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,425見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥38,850見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥58,275見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

SummaryBiostime International Holdings Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Findings
- Detailed information on Biostime International Holdings Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biostime International Holdings Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Biostime International Holdings Ltd including a breakdown and examination of key business segments
- Intelligence on Biostime International Holdings Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biostime International Holdings Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy
- Gain understanding of Biostime International Holdings Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biostime International Holdings Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Biostime International Holdings Ltd’s business structure, strategy and prospects.

Key Highlights
Biostime International Holdings Ltd (Biostime) is a provider of pediatric nutrition and baby care products based in China. The company offers probiotic supplements, infant formula, dried baby food, nutrition supplements and baby care products under five brands: Adimil, Biostime, Parenting Power, BMcare and Mama100. It also offers various value-added services including, professional magazine, mama100 mobile app, nursing consulting hotline, mama100.com website, training program and membership point accumulation program to its members and member retail outlets through its MAMA100 membership platform. The company owns high penetration and wide distribution network through its sales offices located across China. Biostime is headquartered in Guangzhou, China.

【レポートの目次】

Company Snapshot
Biostime International Holdings Ltd: Company Overview
Biostime International Holdings Ltd: Overview and Key Facts
Biostime International Holdings Ltd: Overview
Biostime International Holdings Ltd: Key Facts
Biostime International Holdings Ltd: Key Employees
Biostime International Holdings Ltd: Key Employee Biographies
Biostime International Holdings Ltd: Major Products and Services
Biostime International Holdings Ltd: Company History
Biostime International Holdings Ltd: Management Statement
Biostime International Holdings Ltd: Locations and Subsidiaries
Biostime International Holdings Ltd: Key Competitors
Biostime International Holdings Ltd: Company Analysis
Biostime International Holdings Ltd: Business Description
Biostime International Holdings Ltd: SWOT Analysis
Biostime International Holdings Ltd: SWOT Overview
Biostime International Holdings Ltd: Strengths
Biostime International Holdings Ltd: Weaknesses
Biostime International Holdings Ltd: Opportunities
Biostime International Holdings Ltd: Threats
Biostime International Holdings Ltd: Corporate Financial Deals Activity
Biostime International Holdings Ltd: Financial Deals Overview
Biostime International Holdings Ltd: Targets and Partners
Biostime International Holdings Ltd: Top Deals 2013 – 2017YTD*
Biostime International Holdings Ltd: Mergers and Acquisitions
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

Table 1: Biostime International Holdings Ltd: Key Facts
Table 2: Biostime International Holdings Ltd: Key Employees
Table 4: Biostime International Holdings Ltd: Key Competitors
Table 5: Biostime International Holdings Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Biostime International Holdings Ltd: MandA Average Deal Size - Value (US$m)
Table 7: Biostime International Holdings Ltd: Targets and Partners
Table 8: Biostime International Holdings Ltd: Top Deals 2013 - 2017YTD*
Table 9: Biostime International Holdings Ltd: MandA Volume and Value Trend (2013 - YTD*2017)
Table 10: Biostime International Holdings Ltd: MandA Activity by Geography (2013 - YTD*2017)

Figure 1: Biostime International Holdings Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Figure 2: Biostime International Holdings Ltd: MandA Average Deal Size - Value (US$m)
Figure 3: Biostime International Holdings Ltd: MandA Volume and Value Trend (2013 - YTD*2017)
Figure 4: Biostime International Holdings Ltd: MandA Activity by Geography (2013 - YTD*2017)

★調査レポート[Biostime International Holdings Ltd:企業の戦略・SWOT・財務分析] (コード:MLINE7091022)販売に関する免責事項を必ずご確認ください。
★調査レポート[Biostime International Holdings Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆